Area of research
Genetics · Psychiatry and Mental health
Research interest
Research interests include Genetics, Biology, Epilepsy, Medicine, Phenotype, and Neuroscience.
Phenotypic Spectrum in Individuals With Pathogenic <i>GABRG2</i> Loss- and Gain-of-Function Variants
Bi-allelic pathogenic variants in TRMT1 disrupt tRNA modification and induce a neurodevelopmental disorder
The Spectrum of Neurologic Phenotypes Associated With <scp><i>NUS1</i></scp> Pathogenic Variants: A Comprehensive Case Series
GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy
Germline mutations in a G protein identify signaling cross-talk in T cells
Diagnostic utility of DNA methylation analysis in genetically unsolved pediatric epilepsies and CHD2 episignature refinement
Understanding paralogous epilepsy–associated GABA <sub>A</sub> receptor variants: Clinical implications, mechanisms, and potential pitfalls
<i>De novo</i> and inherited monoallelic variants in <i>TUBA4A</i> cause ataxia and spasticity
RORA-neurodevelopmental disorder: A unique triad of developmental disabilities, cerebellar anomalies, and myoclonic seizures
Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders
Biallelic pathogenic variants in TRMT1 disrupt tRNA modification and induce a syndromic neurodevelopmental disorder
Episignatures in practice: independent evaluation of published episignatures for the molecular diagnostics of ten neurodevelopmental disorders
Gain-of-function and loss-of-function variants in <i>GRIA3</i> lead to distinct neurodevelopmental phenotypes
Delineation of the adult phenotype of Coffin–Siris syndrome in 35 individuals
<i>WWOX</i>developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk
<i><scp>KCNT2</scp>‐</i>Related Disorders: Phenotypes, Functional, and Pharmacological Properties
<scp><i>SORD</i></scp>‐related peripheral neuropathy in a French and Swiss cohort: Clinical features, genetic analyses, and sorbitol dosages
Developmental epileptic encephalopathy in <i>DLG4</i>‐related synaptopathy
BRAT1–related disorders: phenotypic spectrum and phenotype-genotype correlations from 97 patients
Exome sequencing of ATP1A3-negative cases of alternating hemiplegia of childhood reveals SCN2A as a novel causative gene
The gain of function <i>SCN1A</i> disorder spectrum: novel epilepsy phenotypes and therapeutic implications
Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies
Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases
Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism
Gain of function due to increased opening probability by two <i>KCNQ5</i> pore variants causing developmental and epileptic encephalopathy
DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling
Missense variants in ANKRD11 cause KBG syndrome by impairment of stability or transcriptional activity of the encoded protein
The different clinical facets of SYN1-related neurodevelopmental disorders
CDK13-related disorder: Report of a series of 18 previously unpublished individuals and description of an epigenetic signature